Biologics Market By Product Type (Monoclonal Antibodies, Vaccines, Recombinant Proteins, Antisense & RNAi Therapeutics, Others), By Manufacturing (Outsourced, In-house), By Application (Oncology, Immunology, Infectiuos Disease, Cardiovascular Disorders, Others), By Source (Microbial, Mammalian, Others), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034
Report Overview The Biologics Market Size is expected to be worth around US$ 1382.7 billion by 2034 from US$ 514.1 billion in 2024, growing at a CAGR of 10.4% during the forecast per...
